US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist
  • 8.230
  • +0.600+7.86%
Close Apr 26 16:00 ET
  • 8.220
  • -0.010-0.12%
Post 18:34 ET
1.12BMarket Cap-1793P/E (TTM)

Vir Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-146.82%-778.79M
-407.26%-107.93M
-232.17%-155.83M
-140.54%-389.25M
-122.87%-125.78M
3,595.04%1.66B
356.48%35.13M
211.42%117.9M
585.53%960.14M
714.43%550.09M
Net income from continuing operations
-219.25%-615.12M
-14.14%-115.97M
-193.21%-163.41M
-154.63%-194.78M
-127.18%-140.96M
-2.41%515.84M
-119.34%-101.6M
58.76%175.31M
-223.75%-76.49M
407.04%518.62M
Depreciation and amortization
186.76%19.45M
129.34%4.48M
172.65%4.59M
197.49%4.75M
263.27%5.64M
16.73%6.78M
28.40%1.95M
13.19%1.68M
13.84%1.6M
10.70%1.55M
Deferred tax
93.00%-1.06M
----
----
----
----
-200.00%-15.19M
----
----
----
----
Other non cash items
-110.10%-27.99M
24.24%5.17M
71.95%-11.43M
-97.88%8.69M
68.13%-30.41M
224.29%277.23M
-84.18%4.16M
-406.95%-40.77M
974,509.52%409.25M
-307.58%-95.41M
Change In working capital
-145.78%-304.59M
-125.23%-32.75M
46.01%-29.69M
-143.11%-252.88M
174.02%10.73M
205.88%665.37M
121.25%129.82M
38.97%-55M
937.67%586.63M
-75.74%3.91M
-Change in receivables
-100.07%-565K
-101.30%-3.61M
--0
-99.89%948K
100.47%2.09M
199.61%770.04M
140.90%278.17M
162.56%58.18M
--883.77M
---450.08M
-Change in prepaid assets
265.07%64.97M
121.39%10.78M
63.06%26.9M
440.77%17.81M
3,943.32%9.49M
-973.89%-39.36M
-808.91%-50.38M
1,115.55%16.5M
-1,138.15%-5.23M
-126.19%-247K
-Change in payables and accrued expense
-2,317.55%-355.77M
52.54%-36.95M
35.43%-54.68M
7.91%-266.66M
-99.42%2.53M
-125.23%-14.72M
-206.98%-77.86M
-3,015.11%-84.68M
-10,478.49%-289.56M
2,271.29%437.39M
-Change in other current assets
118.32%2.16M
127.64%2.31M
162.86%2.13M
-260.75%-299K
-774.01%-1.98M
-695.35%-11.8M
-1,835.42%-8.36M
-1,648.97%-3.39M
123.43%186K
-260.32%-227K
-Change in other current liabilities
-137.11%-13.05M
-6.13%-3.14M
-139.41%-3.68M
-503.08%-3.13M
-529.82%-3.11M
-928.41%-5.5M
-1,844.08%-2.96M
-429.31%-1.54M
-435.05%-519K
-12,425.00%-493K
-Change in other working capital
92.96%-2.35M
75.67%-2.14M
99.08%-369K
23.92%-1.54M
-90.33%1.7M
-136.18%-33.3M
-454.31%-8.79M
-4,386.56%-40.07M
-103.67%-2.02M
-50.34%17.58M
Cash from discontinued investing activities
Operating cash flow
-146.82%-778.79M
-407.26%-107.93M
-232.17%-155.83M
-140.54%-389.25M
-122.87%-125.78M
3,595.04%1.66B
356.48%35.13M
211.42%117.9M
585.53%960.14M
714.43%550.09M
Investing cash flow
Cash flow from continuing investing activities
113.79%164.63M
31.56%-104.81M
91.10%-58.95M
184.57%230.32M
193.06%98.08M
-747.54%-1.19B
59.44%-153.14M
-997.12%-662.61M
-461.30%-272.33M
-220.40%-105.39M
Net PPE purchase and sale
68.28%-21.57M
87.81%-1.54M
80.43%-3.71M
54.09%-9.46M
56.62%-6.87M
-211.71%-68.01M
3.63%-12.6M
-216.26%-18.98M
-891.77%-20.6M
-2,273.16%-15.83M
Net investment purchase and sale
116.54%186.2M
26.51%-103.28M
91.42%-55.24M
195.25%239.77M
217.18%104.95M
-845.78%-1.13B
61.44%-140.54M
-905.93%-643.62M
-425.01%-251.73M
-201.54%-89.56M
Cash from discontinued investing activities
Investing cash flow
113.79%164.63M
31.56%-104.81M
91.10%-58.95M
184.57%230.32M
193.06%98.08M
-747.54%-1.19B
59.44%-153.14M
-997.12%-662.61M
-461.30%-272.33M
-220.40%-105.39M
Financing cash flow
Cash flow from continuing financing activities
-78.48%7.48M
-16.46%1.68M
-86.05%277K
3.21%3.18M
-91.53%2.34M
-65.35%34.76M
-64.53%2.01M
-45.30%1.99M
-12.72%3.08M
-68.36%27.69M
Net issuance payments of debt
-10.38%-287K
-12.99%-87K
-11.86%-66K
-13.33%-68K
-3.13%-66K
-0.39%-260K
-6.94%-77K
3.28%-59K
6.25%-60K
-3.23%-64K
Net common stock issuance
--0
--0
--0
--0
--0
-66.60%28.46M
--0
--0
--0
-66.60%28.46M
Proceeds from stock option exercised by employees
0.14%7.77M
-15.37%1.77M
-83.22%343K
6.59%3.35M
377.27%2.31M
-49.56%7.76M
-63.64%2.09M
-44.61%2.04M
-12.61%3.14M
-79.42%484K
Net other financing activities
----
----
----
----
108.35%100K
---1.2M
--0
--0
--0
---1.2M
Cash from discontinued financing activities
Financing cash flow
-78.48%7.48M
-16.46%1.68M
-86.05%277K
3.21%3.18M
-91.53%2.34M
-65.35%34.76M
-64.53%2.01M
-45.30%1.99M
-12.72%3.08M
-68.36%27.69M
Net cash flow
Beginning cash position
138.84%867.97M
-52.00%472.35M
-55.01%686.86M
0.82%842.61M
138.84%867.97M
-19.51%363.42M
35.23%983.97M
101.95%1.53B
55.64%835.8M
-19.51%363.42M
Current changes in cash
-220.24%-606.68M
-81.95%-211.06M
60.48%-214.51M
-122.54%-155.75M
-105.37%-25.36M
672.89%504.55M
68.15%-116M
-1,816.04%-542.72M
215.53%690.89M
452.44%472.38M
End cash Position
-69.90%261.29M
-69.90%261.29M
-52.00%472.35M
-55.01%686.86M
0.82%842.61M
138.84%867.97M
138.84%867.97M
35.23%983.97M
101.95%1.53B
55.64%835.8M
Free cash flow
-150.17%-800.36M
-585.38%-109.46M
-261.30%-159.54M
-142.44%-398.7M
-124.83%-132.65M
2,398.43%1.6B
519.81%22.55M
188.45%98.91M
580.92%939.54M
692.32%534.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -146.82%-778.79M-407.26%-107.93M-232.17%-155.83M-140.54%-389.25M-122.87%-125.78M3,595.04%1.66B356.48%35.13M211.42%117.9M585.53%960.14M714.43%550.09M
Net income from continuing operations -219.25%-615.12M-14.14%-115.97M-193.21%-163.41M-154.63%-194.78M-127.18%-140.96M-2.41%515.84M-119.34%-101.6M58.76%175.31M-223.75%-76.49M407.04%518.62M
Depreciation and amortization 186.76%19.45M129.34%4.48M172.65%4.59M197.49%4.75M263.27%5.64M16.73%6.78M28.40%1.95M13.19%1.68M13.84%1.6M10.70%1.55M
Deferred tax 93.00%-1.06M-----------------200.00%-15.19M----------------
Other non cash items -110.10%-27.99M24.24%5.17M71.95%-11.43M-97.88%8.69M68.13%-30.41M224.29%277.23M-84.18%4.16M-406.95%-40.77M974,509.52%409.25M-307.58%-95.41M
Change In working capital -145.78%-304.59M-125.23%-32.75M46.01%-29.69M-143.11%-252.88M174.02%10.73M205.88%665.37M121.25%129.82M38.97%-55M937.67%586.63M-75.74%3.91M
-Change in receivables -100.07%-565K-101.30%-3.61M--0-99.89%948K100.47%2.09M199.61%770.04M140.90%278.17M162.56%58.18M--883.77M---450.08M
-Change in prepaid assets 265.07%64.97M121.39%10.78M63.06%26.9M440.77%17.81M3,943.32%9.49M-973.89%-39.36M-808.91%-50.38M1,115.55%16.5M-1,138.15%-5.23M-126.19%-247K
-Change in payables and accrued expense -2,317.55%-355.77M52.54%-36.95M35.43%-54.68M7.91%-266.66M-99.42%2.53M-125.23%-14.72M-206.98%-77.86M-3,015.11%-84.68M-10,478.49%-289.56M2,271.29%437.39M
-Change in other current assets 118.32%2.16M127.64%2.31M162.86%2.13M-260.75%-299K-774.01%-1.98M-695.35%-11.8M-1,835.42%-8.36M-1,648.97%-3.39M123.43%186K-260.32%-227K
-Change in other current liabilities -137.11%-13.05M-6.13%-3.14M-139.41%-3.68M-503.08%-3.13M-529.82%-3.11M-928.41%-5.5M-1,844.08%-2.96M-429.31%-1.54M-435.05%-519K-12,425.00%-493K
-Change in other working capital 92.96%-2.35M75.67%-2.14M99.08%-369K23.92%-1.54M-90.33%1.7M-136.18%-33.3M-454.31%-8.79M-4,386.56%-40.07M-103.67%-2.02M-50.34%17.58M
Cash from discontinued investing activities
Operating cash flow -146.82%-778.79M-407.26%-107.93M-232.17%-155.83M-140.54%-389.25M-122.87%-125.78M3,595.04%1.66B356.48%35.13M211.42%117.9M585.53%960.14M714.43%550.09M
Investing cash flow
Cash flow from continuing investing activities 113.79%164.63M31.56%-104.81M91.10%-58.95M184.57%230.32M193.06%98.08M-747.54%-1.19B59.44%-153.14M-997.12%-662.61M-461.30%-272.33M-220.40%-105.39M
Net PPE purchase and sale 68.28%-21.57M87.81%-1.54M80.43%-3.71M54.09%-9.46M56.62%-6.87M-211.71%-68.01M3.63%-12.6M-216.26%-18.98M-891.77%-20.6M-2,273.16%-15.83M
Net investment purchase and sale 116.54%186.2M26.51%-103.28M91.42%-55.24M195.25%239.77M217.18%104.95M-845.78%-1.13B61.44%-140.54M-905.93%-643.62M-425.01%-251.73M-201.54%-89.56M
Cash from discontinued investing activities
Investing cash flow 113.79%164.63M31.56%-104.81M91.10%-58.95M184.57%230.32M193.06%98.08M-747.54%-1.19B59.44%-153.14M-997.12%-662.61M-461.30%-272.33M-220.40%-105.39M
Financing cash flow
Cash flow from continuing financing activities -78.48%7.48M-16.46%1.68M-86.05%277K3.21%3.18M-91.53%2.34M-65.35%34.76M-64.53%2.01M-45.30%1.99M-12.72%3.08M-68.36%27.69M
Net issuance payments of debt -10.38%-287K-12.99%-87K-11.86%-66K-13.33%-68K-3.13%-66K-0.39%-260K-6.94%-77K3.28%-59K6.25%-60K-3.23%-64K
Net common stock issuance --0--0--0--0--0-66.60%28.46M--0--0--0-66.60%28.46M
Proceeds from stock option exercised by employees 0.14%7.77M-15.37%1.77M-83.22%343K6.59%3.35M377.27%2.31M-49.56%7.76M-63.64%2.09M-44.61%2.04M-12.61%3.14M-79.42%484K
Net other financing activities ----------------108.35%100K---1.2M--0--0--0---1.2M
Cash from discontinued financing activities
Financing cash flow -78.48%7.48M-16.46%1.68M-86.05%277K3.21%3.18M-91.53%2.34M-65.35%34.76M-64.53%2.01M-45.30%1.99M-12.72%3.08M-68.36%27.69M
Net cash flow
Beginning cash position 138.84%867.97M-52.00%472.35M-55.01%686.86M0.82%842.61M138.84%867.97M-19.51%363.42M35.23%983.97M101.95%1.53B55.64%835.8M-19.51%363.42M
Current changes in cash -220.24%-606.68M-81.95%-211.06M60.48%-214.51M-122.54%-155.75M-105.37%-25.36M672.89%504.55M68.15%-116M-1,816.04%-542.72M215.53%690.89M452.44%472.38M
End cash Position -69.90%261.29M-69.90%261.29M-52.00%472.35M-55.01%686.86M0.82%842.61M138.84%867.97M138.84%867.97M35.23%983.97M101.95%1.53B55.64%835.8M
Free cash flow -150.17%-800.36M-585.38%-109.46M-261.30%-159.54M-142.44%-398.7M-124.83%-132.65M2,398.43%1.6B519.81%22.55M188.45%98.91M580.92%939.54M692.32%534.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg